CEN BIOTECH INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2021 to Q1 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Cen Biotech Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2022.
- Cen Biotech Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2022 was $0.000.
- Cen Biotech Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$2.74K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)